Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950120-08-000262
Filing Date
2008-06-06
Accepted
2008-06-06 18:11:33
Documents
1
Period of Report
2008-06-04

Document Format Files

Seq Description Document Type Size
1 biologika-emerform4_0606ex.html 4  
1 biologika-emerform4_0606ex.xml 4 36798
  Complete submission text file 0000950120-08-000262.txt   38709
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Issuer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11308 GLEN RD. POTOMAC MD 20854
Business Address 11308 GLEN RD. POTOMAC MD 20854 301-983-2295
Biologika, L.L.C. (Reporting) CIK: 0001380794 (see all company filings)

State of Incorp.: MD | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-33137 | Film No.: 08886729